TG Therapeutics, Inc. (TGTX)
NASDAQ: TGTX · Real-Time Price · USD
35.71
+0.57 (1.62%)
At close: May 29, 2025, 4:00 PM
35.26
-0.45 (-1.26%)
After-hours: May 29, 2025, 7:45 PM EDT

TG Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
May '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
5,2074,3202,4161,5842,4886,703
Upgrade
Market Cap Growth
160.03%78.80%52.51%-36.33%-62.88%515.51%
Upgrade
Enterprise Value
5,1854,2332,2971,4912,1596,490
Upgrade
Last Close Price
35.7130.1017.0811.8319.0052.02
Upgrade
PE Ratio
149.96184.75190.66---
Upgrade
Forward PE
30.7445.21----
Upgrade
PS Ratio
13.4413.1310.34568.84371.9644096.70
Upgrade
PB Ratio
21.8619.4315.0527.0410.4912.91
Upgrade
P/TBV Ratio
21.9419.4315.0527.4110.5312.93
Upgrade
EV/Sales Ratio
13.4212.879.83535.24322.8242698.06
Upgrade
EV/EBITDA Ratio
86.61100.79110.20---
Upgrade
EV/EBIT Ratio
86.68100.95111.33---
Upgrade
Debt / Equity Ratio
1.071.140.691.420.340.08
Upgrade
Debt / EBITDA Ratio
4.105.744.82---
Upgrade
Asset Turnover
0.750.730.890.010.010
Upgrade
Inventory Turnover
0.410.51----
Upgrade
Quick Ratio
2.914.855.003.044.846.92
Upgrade
Current Ratio
4.026.255.923.165.066.99
Upgrade
Return on Equity (ROE)
19.70%12.21%11.57%-151.36%-92.03%-100.14%
Upgrade
Return on Assets (ROA)
7.26%5.78%4.93%-47.61%-42.87%-43.36%
Upgrade
Return on Capital (ROIC)
9.79%7.00%6.24%-59.52%-49.04%-53.28%
Upgrade
Return on Capital Employed (ROCE)
12.00%8.60%7.50%---
Upgrade
Earnings Yield
0.75%0.54%0.52%-14.13%-13.99%-4.17%
Upgrade
FCF Yield
-1.17%-0.94%-1.30%-11.12%-11.90%-3.21%
Upgrade
Buyback Yield / Dilution
-9.66%-7.96%-9.67%-2.41%-14.64%-30.51%
Upgrade
Updated May 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q